HIGHLIGHTS
- who: Dominique J. Barbeau from the Human subjects research A convenience sample of participants , years of age and older were prospectively enrolled if they were planning to receive two doses of m, or BNT162b2, or a single dose of Ad COV2.S under FDA EUA between December , and March , either in an occupational or a community setting. After obtaining written informed consent, whole blood was obtained in cell preparation tubes (BD) on the day of enrollment/first vaccination, and during follow up visits. Plasma and peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved using standard methods . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.